from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3659c/-

LFCtreatmentdescriptionclass of inhibitor

1.333

Amikacinug/mL Amikacintranslation

-0.144

Cap5-10ug/mL Capreomycintranslation

-0.229

Rox10-50 ug/mL Roxithromycintranslation

-0.135

SM2-5 ug/mL Streptomycintranslation

-0.229

Tet5-10 ug/mL Tetracyclinetranslation

0.783

Rif0.2-5ug/mL Rifampicintranscription

-0.549

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.576

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.326

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.083

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.715

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.628

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.118

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.603

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.268

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.745

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.193

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.049

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.226

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.118

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.030

Nigericin50 uM Nigericinrespiration

-0.845

TRC10-150 ug/mL Triclosanrespiration

0.329

TRZ10-25 ug/mL Thioridazinerespiration

2.478

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.434

menadione6-10 ug/mL Menadionerespiration

0.094

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.229

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.211

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.050

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.093

NRP_1Non-replicating persistence stage 1dosRassociated

0.585

Amp0.2mg/mL AmpicillincellWall

-0.433

Cephalexin20-100 ug/mL CephalexincellWall

-0.777

Cerulenin0.32-5 ug/mL CerulenincellWall

0.175

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.012

EMB10-20 ug/mL EthambutolcellWall

0.030

Eta12-40 ug/mL EthionamidecellWall

0.006

INH0.2-0.4 ug/mL IsoniazidcellWall

0.812

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.099

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.867

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.109

BZA0.12 mg/mL BenzamidearomaticAmides

-0.068

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.393

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.081

H2O24 mM hydrogen peroxideDNAdamaging

0.357

Levo10 ug/mL LevofloxacinDNAdamaging

-0.079

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.504

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.335

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.275

UVUV-irradiationDNAdamaging

0.794

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.376

Antimycin12.5-50 ug/mL Antimycin A?

-0.145

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.760

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.517

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.199

PA8240.2-2 ug/mL PA-824?

-1.171

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.780

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.573

Verapamil50 uM Verapamil?

0.215

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.078

methoxatin10-20 ug/mL Methoxatin?